Global DNA sequencing market projected to reach USD 52.1 billion by 2032 with a CAGR of 17.8%
From GlobeNewswire: 2025-04-04 09:40:00
The DNA Sequencing Market was valued at USD 11.5 billion in 2023 and is projected to reach USD 52.1 billion by 2032, with a CAGR of 17.8%. Advancements in sequencing technologies, applications in clinical diagnostics, and demand for personalized medicine are driving this growth. North America leads in market presence, while Asia-Pacific shows potential for future growth.
In 2023, the oncology segment led the DNA sequencing market, representing 24% of revenue. DNA sequencing plays a vital role in oncology research and diagnostics, enabling early cancer detection and personalized treatment. The reproductive health segment is expected to experience the highest growth, driven by increased utilization in genetic disorder detection and regulatory approvals for genetic testing.
Consumables accounted for 48% of revenue in the DNA sequencing market in 2023, with the services segment expected to grow rapidly. The trend of outsourcing sequencing services for clinical diagnostics and pharmaceutical research is fueling this growth. Academic research leads in revenue share, while the clinical research segment is projected to grow at the highest rate during the forecast period.
North America dominates the DNA sequencing market, with 36% of the global market share in 2023. The region benefits from strong government support, established research institutions, and major industry players. The Asia-Pacific region is expected to show the highest growth potential, driven by expanding genome-based research programs and increasing adoption of sequencing technologies. The DNA sequencing market is experiencing growth due to increased investments, partnerships, and government support. Recent developments include PacBio acquiring Apton Biosystems, Illumina introducing PrimateAI-3D, and the NHGRI initiative to reduce sequencing costs. Globally, over 4 million whole-genome sequencing procedures were conducted in 2023, with the US leading in funding and adoption. The Asia-Pacific region is expected to contribute significantly to new installations, with over 70% of major hospitals incorporating genomic sequencing into diagnostics.
For more information on the DNA sequencing market analysis and outlook, visit the link provided. SNS Insider is a leading market research agency offering insights to help clients navigate changing market conditions. With a focus on providing current and accurate data, SNS Insider utilizes various research techniques to deliver valuable market insights for confident decision-making.
Read more at GlobeNewswire: Global DNA Sequencing Market Size Projected to Hit USD 52.1